Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 308 entries
View as:

A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00382304 Org: User:
Start: 09/30/06 End: 09/30/07 Due: 09/30/08

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00496509 Org: User:
Start: 08/31/06 End: 10/31/07 Due: 10/31/08

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

Phase: N/A Priority: Normal
NCT ID: NCT00930553 Org: User:
Start: 08/31/09 End: 02/29/16 Due: 02/28/17

Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01898364 Org: User:
Start: 08/19/13 End: 02/25/15 Due: 02/25/16

Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim

Phase: N/A Priority: Normal
NCT ID: NCT00206713 Org: User:
Start: 07/31/04 End: 10/31/06 Due: 10/31/07

A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.

Phase: N/A Priority: Normal
NCT ID: NCT00293163 Org: User:
Start: 02/28/06 End: 10/31/06 Due: 10/31/07

An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02332811 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00778479 Org: User:
Start: 10/31/08 End: 05/31/09 Due: 05/31/10

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00071188 Org: User:
Start: 02/29/04 End: 10/31/07 Due: 10/31/08

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor

Phase: N/A Priority: Normal
NCT ID: NCT01362985 Org: User:
Start: 07/31/09 End: 07/31/14 Due: 07/31/15

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT00074932 Org: User:
Start: 11/30/04 End: 12/31/06 Due: 12/31/07

An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT00701129 Org: User:
Start: 10/31/09 End: 03/31/13 Due: 03/31/14

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00043706 Org: User:
Start: - End: 09/30/03 Due: 09/30/04

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00088543 Org: User:
Start: 03/31/04 End: 04/30/06 Due: 04/30/07

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Phase: N/A Priority: Normal
NCT ID: NCT02306811 Org: User:
Start: 02/28/15 End: 07/31/16 Due: 07/31/17

A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT01196013 Org: User:
Start: 08/31/10 End: 05/31/11 Due: 05/31/12

AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone

Phase: N/A Priority: Normal
NCT ID: NCT00395967 Org: User:
Start: 04/30/05 End: 08/31/06 Due: 08/31/07

A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00466635 Org: User:
Start: 04/30/07 End: 08/31/07 Due: 08/31/08

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00130715 Org: User:
Start: 06/30/98 End: 08/31/03 Due: 08/31/04

Effect of Venglustat in Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03687554 Org: User:
Start: 10/05/18 End: 02/27/19 Due: 02/27/20

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

Phase: N/A Priority: Normal
NCT ID: NCT03754790 Org: User:
Start: 01/09/19 End: 11/05/26 Due: 11/05/27

Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00777179 Org: User:
Start: 10/31/08 End: 12/31/11 Due: 12/31/12

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Phase: N/A Priority: Normal
NCT ID: NCT01288573 Org: User:
Start: 03/03/14 End: 05/09/17 Due: 05/09/18

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00086580 Org: User:
Start: 07/31/04 End: 06/30/10 Due: 06/30/11

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Phase: N/A Priority: Normal
NCT ID: NCT00324571 Org: User:
Start: 03/31/01 End: 02/28/06 Due: 02/28/07